RELAY THERAPEUTICS Trademark

Trademark Overview

On Friday, October 26, 2018, a trademark application was filed for RELAY THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RELAY THERAPEUTICS trademark a serial number of 88979360. The federal status of this trademark filing is REGISTERED as of Tuesday, November 24, 2020. This trademark is owned by Relay Therapeutics, Inc.. The RELAY THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development services in the field of allosteric regulation; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic products
relay therapeutics

General Information

Serial Number88979360
Word MarkRELAY THERAPEUTICS
Filing DateFriday, October 26, 2018
Status700 - REGISTERED
Status DateTuesday, November 24, 2020
Registration Number6205848
Registration DateTuesday, November 24, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesBiochemical research and development services in the field of allosteric regulation; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic products
Description of MarkThe mark consists of a geometrical figure design, consisting of two quadrilaterals intersecting, to the left of the wording "RELAY" in large font above "THERAPEUTICS" in smaller font.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 11, 2018
Primary Code042
First Use Anywhere DateThursday, March 31, 2016
First Use In Commerce DateWednesday, September 14, 2016

Trademark Owner History

Party NameRelay Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRelay Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRelay Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, October 30, 2018NEW APPLICATION ENTERED
Sunday, November 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 13, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 2, 2019ASSIGNED TO EXAMINER
Thursday, February 7, 2019NON-FINAL ACTION WRITTEN
Thursday, February 7, 2019NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 1, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 1, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 17, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, August 17, 2019EXAMINERS AMENDMENT E-MAILED
Saturday, August 17, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, August 17, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, August 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 17, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 21, 2020TEAS REQUEST TO DIVIDE RECEIVED
Thursday, April 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 21, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, October 21, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, April 21, 2020NOTICE OF ALLOWANCE CANCELLED
Wednesday, October 21, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, October 22, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 24, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, January 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 4, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 4, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 24, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics relay development research field therapeutic discovery scientific pharmaceuticals drug services diseases